tiprankstipranks
Trending News
More News >
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
US Market

Apimeds Pharmaceuticals US, Inc. (APUS) Balance Sheet

Compare
17 Followers

Apimeds Pharmaceuticals US, Inc. Balance Sheet

Apimeds Pharmaceuticals US, Inc.'s total assets for Q3 2025 were $9.25M, a decrease of -12.29% from the previous quarter. APUS total liabilities were $1.09M for the fiscal quarter, a 34.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 13.06K$ 422.08K$ 6.17K$ 172.17K
Total Liabilities
$ 1.37M$ 390.20K$ 719.78K$ 410.65K
Total Equity Gross Minority
$ -1.36M$ 31.87K$ -713.61K$ -238.48K
Other Metrics
Currency in USD

Apimeds Pharmaceuticals US, Inc. Debt to Assets